• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国外分泌和内分泌胰腺肿瘤的发病率。

Incidence rates of exocrine and endocrine pancreatic cancers in the United States.

机构信息

United States Military Cancer Institute, Walter Reed Army Medical Center, Building 1, Suite A-109, 6900 Georgia Ave, NW, Washington, DC 20307, USA.

出版信息

Cancer Causes Control. 2010 Jun;21(6):853-61. doi: 10.1007/s10552-010-9512-y. Epub 2010 Feb 25.

DOI:10.1007/s10552-010-9512-y
PMID:20182788
Abstract

Descriptive studies of pancreatic cancer incidence have been sparse particularly in terms of tumor histology and stage. The purpose of this study was to examine the incidence rate trends of exocrine and endocrine pancreatic cancers by demographic and tumor characteristics using data from the Surveillance, Epidemiology, and End Results (SEER) program from 1977 to 2005. During this period, the incidence of exocrine pancreatic cancer generally decreased whereas the incidence of endocrine pancreatic cancer increased. This difference in trends by histology was evident across age, gender, and racial groups. It was also evident among different racial/ethnic groups using data from 1992 to 2005. Variation in trends was observed by stage. The incidence of exocrine cancers declined for all stages except regional. Endocrine cancer incidence increased for all tumor stages, and the increase was most prominent for localized tumors. When exocrine tumors were stratified by tumor subsite, the incidence of cancers in the tail and body regions increased while the incidence in other regions decreased. While better detection and classification of tumors through improved diagnostic procedures may be related to these changing trends, etiologic factors warrant study.

摘要

对胰腺癌发病率的描述性研究一直很少,特别是在肿瘤组织学和分期方面。本研究的目的是通过监测、流行病学和最终结果(SEER)计划 1977 年至 2005 年的数据,按人口统计学和肿瘤特征检查外分泌和内分泌胰腺肿瘤的发病率趋势。在此期间,外分泌胰腺肿瘤的发病率普遍下降,而内分泌胰腺肿瘤的发病率上升。这种组织学趋势的差异在年龄、性别和种族群体中都很明显。1992 年至 2005 年的数据也表明了不同种族/民族群体之间的这种差异。不同分期的趋势也有所不同。除了局部肿瘤外,所有分期的外分泌癌发病率均下降。所有肿瘤分期的内分泌癌发病率均上升,局部肿瘤的发病率上升最为明显。当通过肿瘤亚部位对外分泌肿瘤进行分层时,尾部和体部区域癌症的发病率增加,而其他区域的发病率则下降。虽然通过改进诊断程序更好地检测和分类肿瘤可能与这些变化趋势有关,但病因因素仍需要研究。

相似文献

1
Incidence rates of exocrine and endocrine pancreatic cancers in the United States.美国外分泌和内分泌胰腺肿瘤的发病率。
Cancer Causes Control. 2010 Jun;21(6):853-61. doi: 10.1007/s10552-010-9512-y. Epub 2010 Feb 25.
2
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.《1975 - 2002年全国癌症状况年度报告》,重点介绍基于人群的癌症治疗趋势。
J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27. doi: 10.1093/jnci/dji289.
3
Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States.美国基于人群的研究:胰头、体和尾部癌症的发病率和生存率。
Pancreas. 2010 May;39(4):458-62. doi: 10.1097/MPA.0b013e3181bd6489.
4
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.1992 - 2001年按结直肠癌发病部位、诊断时分期及种族/族裔划分的长期变化情况
Cancer. 2006 Sep 1;107(5 Suppl):1142-52. doi: 10.1002/cncr.22011.
5
Population-based study of islet cell carcinoma.基于人群的胰岛细胞癌研究。
Ann Surg Oncol. 2007 Dec;14(12):3492-500. doi: 10.1245/s10434-007-9566-6. Epub 2007 Sep 26.
6
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994.美国结直肠癌的发病率:1975 - 1994年按性别、种族、年龄、亚部位和分期划分的趋势更新
Cancer. 1999 Apr 15;85(8):1670-6.
7
Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.1999 - 2004年美国结直肠癌发病率:来自国家癌症登记计划和监测、流行病学及最终结果计划数据的更新分析
Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216.
8
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.恶性胰腺肿瘤:58例儿科患者的发病率及转归
J Pediatr Surg. 2009 Jan;44(1):197-203. doi: 10.1016/j.jpedsurg.2008.10.039.
9
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.1975 - 2001年美国癌症现状年度报告,附生存情况专题内容
Cancer. 2004 Jul 1;101(1):3-27. doi: 10.1002/cncr.20288.
10
Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003.1995 - 2003年美国浸润性阴茎癌发病率的人口统计学和病理学差异
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1833-9. doi: 10.1158/1055-9965.EPI-07-0221.

引用本文的文献

1
Long-term Cancer Survival Trends by Updated Summary Stage.按更新的总结分期的长期癌症生存趋势
Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1508-1517. doi: 10.1158/1055-9965.EPI-23-0589.
2
Contrast-Enhanced Harmonic Endoscopic Ultrasound for Diagnosis of the Aggressiveness of Pancreatic Neuroendocrine Neoplasm.对比增强谐波内镜超声用于诊断胰腺神经内分泌肿瘤的侵袭性
Diagnostics (Basel). 2022 Nov 29;12(12):2988. doi: 10.3390/diagnostics12122988.
3
Annual report to the nation on the status of cancer, part 1: National cancer statistics.
国家癌症报告:癌症统计数据 1. 全国癌症统计数据概览
Cancer. 2022 Dec 15;128(24):4251-4284. doi: 10.1002/cncr.34479. Epub 2022 Oct 27.
4
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.不断发展的胰腺癌外科肿瘤学知识:从理论到临床实践——在一家三级转诊中心的十五年历程。
Updates Surg. 2022 Oct;74(5):1533-1542. doi: 10.1007/s13304-022-01346-x. Epub 2022 Aug 25.
5
Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌的治疗现状与可用策略
Biomedicines. 2021 Feb 11;9(2):178. doi: 10.3390/biomedicines9020178.
6
Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.早发性胰腺神经内分泌肿瘤的临床特征和预后因素。
Cancer Control. 2021 Jan-Dec;28:1073274820986827. doi: 10.1177/1073274820986827.
7
Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.用于预测无功能胰腺神经内分泌肿瘤分级的非增强放射组学方法
J Magn Reson Imaging. 2020 Oct;52(4):1124-1136. doi: 10.1002/jmri.27176. Epub 2020 Apr 28.
8
Emerging incidence trends and application of curative treatments of pancreatic cancer in the USA.美国胰腺癌的新发发病率趋势及治愈性治疗方法的应用
Medicine (Baltimore). 2019 Dec;98(51):e17175. doi: 10.1097/MD.0000000000017175.
9
Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.在靶向治疗和免疫治疗时代,胰腺癌有前景的新疗法。
Am J Cancer Res. 2019 Sep 1;9(9):1871-1888. eCollection 2019.
10
Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.生长抑素与趋化因子 CXCR4 受体在胰腺腺癌与胰腺神经内分泌肿瘤中的表达。
J Cancer Res Clin Oncol. 2019 Oct;145(10):2481-2493. doi: 10.1007/s00432-019-03011-0. Epub 2019 Aug 26.